国际EMCREG多学科共识小组关于慢性病和心力衰竭中高胆血症的管理
Natalie Kreitzer1, Nancy M Albert2, Alpesh N Amin3
1Department of Emergency Medicine, University of Cincinnati, Cincinnati, Ohio, USA.
Cardiorenal medicine
|January 14, 2025
概括
对患有脏疾病和心力衰竭的患者来说,管理高血症或高水平至关重要. 新的结合剂提供了有效的治疗选择,同时保留了必需的药物.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 心脏病学 心脏病学
- 内部医学 内部医学
背景情况:
- 血清高 (血清>5.0mEq/L) 具有显著的风险,包括心脏毒性和肌肉衰弱.
- 在患有慢性病 (CKD),糖尿病和心力衰竭 (HF) 的患者中,患病率增加,特别是在使用某些药物时.
- 慢性病和急性损伤中调节受损增加了风险,复杂化了慢性高血症的管理.
研究的目的:
- 描述跨临床环境的高卡利米亚的最佳,多学科的管理策略.
- 强调对心血管代谢综合征患者的综合护理.
- 概述如何在控制水平的同时保持必需药物的心血管益处的方法.
主要方法:
- 召集了一个由专家组成的共识小组.
- 审查了急性和慢性高血症的当前管理策略.
- 专注于平衡基本疗法与水平控制.
主要成果:
- 急性高血症的管理优先考虑通过细胞稳定和细胞内转移进行心脏保护.
- 慢性高血症的治疗包括饮食,利尿剂和结合剂 (例如,帕蒂罗默,硫环酸盐).
- 新的结合剂在降低慢性血症的CKD/HF患者中表现出有效性,为具有不良影响的旧药物提供了替代品.
结论:
- 多学科的方法对于全面的高血症管理至关重要.
- 新的结合剂为慢性高胆血症提供了有效的选择,特别是在CKD和HF人群中.
- 现有策略可以安全地管理水平,从而能够继续使用重要的心血管和药物.
相关概念视频
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
381
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
381
01:22Heart Failure Drugs: Diuretics
338
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
338
01:33Hormonal Regulation
32.9K
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
32.9K
01:26Heart Failure Drugs: Inotropic Agents
511
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
511
01:28Antihypertensive Drugs: Potassium-Sparing Diuretics
443
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
443
01:11Renal Failure: Dose Adjustments
62
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
62